Company

We are dedicated to studying neurodegenerative diseases and are at the forefront of Alzheimer’s research

A digital representation of a human brain, resembling a neural network
From discovery, through development to clinical trials, regulatory submissions and product registration, our work aims to halt the progression of Alzheimer’s and other types of dementia.

Mission and values

Our goal is to discover, develop and commercialise innovative products for the diagnosis, treatment and cure of dementias caused through protein aggregation.

Company history

Since 2002, we have been on a journey of discovery that has led to global collaborations and thousands of people taking part in clinical trials.

Company leadership

With a wide range of scientific, medical and commercial backgrounds, our leadership team has the passion, drive and commitment to bring to market a drug that will ease the burden of millions around the world.

Investors

We have been fortunate to benefit from the backing of loyal investors from across the globe - enabling us to conduct groundbreaking work on neurodegenerative diseases. 

Environmental, Social and Governance at TauRx

Our scientific teams are dedicated to solving one of the world's greatest unmet medical needs in a responsible manner.